
Dillip Kumar Das
About Dillip Kumar Das
Data last updated:
Dillip Kumar Das is a Director at Bioxel Healthcare Private Limited (since 2015) and Director at Novellus Healthspecialities Private Limited (since 2025). The companies operate in Chemicals. The largest current company by reported revenue is Bioxel Healthcare Private Limited at ₹70 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Apr 2015 | 2015 | ₹70 Lakh (FY 2024) | Active | |
| Director | 23 Apr 2025 | 2025 | Active |
Board colleagues of Dillip Kumar Das
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alaka Pati | 11476241 | Bioxel Healthcare Private Limited | Additional Director |
| Sukanta Kumar Panda | 11071343 | Novellus Healthspecialities Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dillip Kumar Das
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dillip Kumar Das
Dillip Kumar Das currently holds 2 directorships: Bioxel Healthcare Private Limited (Director, since 29 Apr 2015, revenue ₹70 Lakh (FY 2024)); Novellus Healthspecialities Private Limited (Director, since 23 Apr 2025).
Dillip Kumar Das was first appointed on 29 Apr 2015 as Director at Bioxel Healthcare Private Limited. The most recent appointment on record is 23 Apr 2025 at Novellus Healthspecialities Private Limited.
The current boards of Dillip Kumar Das's companies include Alaka Pati (Bioxel Healthcare Private Limited), Sukanta Kumar Panda (Novellus Healthspecialities Private Limited).